Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecast to 2028

Report Summary

Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Infectious Disease Diagnostics market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.

Infectious Disease Diagnostics market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Key Research Highlights: Market Drivers

The Infectious Disease Diagnostics market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Infectious Disease Diagnostics products across developed and developing countries of the world.

Key Research Highlights: Market Restrains

Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Infectious Disease Diagnostics products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Infectious Disease Diagnostics market.

Key Research Highlights: Trends

Increasing research and development spending on Infectious Disease Diagnostics development has been the leading industry trend of Infectious Disease Diagnostics market

The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.

Global Infectious Disease Diagnostics Market Size, 2018-2028 (USD MILLION)

Market Segmentation

Key Market Players

• Bio Mérieux SA
• Roche Diagnostics
• Abbott Laboratories
• Thermo Fischer Scientific
• BD
• Bio-Rad Laboratories
• Abbott
• Danaher
• Johnson and Johnson
• Guangzhou Wondfo Biotech Co.
• Ltd.
• Getein Biotech
• Inc.
• Wuhan Easy Diagnosis Biomedicine Co.
• Ltd.
• BGI Genomics Co.
• Ltd.
• Maccura Pharmaceuticals & Healthcare Co.
• Ltd.
• Daan Gene
• Beijing Strong Biotechnologies
• Inc
• Shanghai Kehua Bio-Engineering Co.
• Ltd.
• Guangdong Hybribio Biotech Co.
• Ltd.
• Shanghai Runda Medical Technology Co.
• Ltd.
• Tellgen Corporation

Infectious Disease Diagnostics Market, By Type

• Molecular Diagnostic Technique
• Traditional Diagnostic Technique
• Other

Infectious Disease Diagnostics Market, By Application

• Hepatitis C
• Hepatitis B
• Tuberculosis (TB)
• Acquired Immunodeficiency Syndrome (AIDS)
• Human Papillomavirus (HPV)
• Methicillin-resistant Staphylococcus Aureus (MRSA)

Key Benefits To The Stake Holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Table Of Contents

1 Methodology and Scope

1.1 Market segmentation & scope
1.2 Information Procurement

1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research

1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing

2 Executive Summary

3 Infectious Disease Diagnostics Market Variables, Trends & Scope

3.1 Market Dynamics

3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator

3.2 Impact of COVID-19 Pandemic on Global Infectious Disease Diagnostics Market

3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis

3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools

3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis

3.9 Key Company Ranking Analysis, 2020

4 Global Infectious Disease Diagnostics Market Analysis and Forecast, By Type

4.1 Overview & Definition
4.2 Key Trends
4.3 Global Infectious Disease Diagnostics Market Value (US$ Mn) Forecast, by Type (2019 – 2028)

4.2.1 Molecular Diagnostic Technique
4.2.2 Traditional Diagnostic Technique
4.2.3 Other

4.4 Type Comparison Matrix
4.5 Global Infectious Disease Diagnostics Market Attractiveness, By Type

5 Global Infectious Disease Diagnostics Market Analysis and Forecast, By Application

5.1 Overview & Definition
5.2 Key Trends
5.3 Global Infectious Disease Diagnostics Market Value (US$ Mn) Forecast, by Application (2019 – 2028)

5.3.1 Hepatitis C
5.3.2 Hepatitis B
5.3.3 Tuberculosis (TB)
5.3.4 Acquired Immunodeficiency Syndrome (AIDS)
5.3.5 Human Papillomavirus (HPV)
5.3.6 Methicillin-resistant Staphylococcus Aureus (MRSA)

5.4 Application Comparison Matrix
5.5 Global Infectious Disease Diagnostics Market Attractiveness, by Application

6 Global Infectious Disease Diagnostics Market Analysis and Forecast, By Region

6.1 Overview & Definition
6.2 Key Trends
6.3 Global Infectious Disease Diagnostics Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa

7 Global Infectious Disease Diagnostics Market Attractiveness, by Region

8 North America Infectious Disease Diagnostics Market Analysis and Forecast

8.1 Key Findings
8.2 North America Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

8.2.1 Molecular Diagnostic Technique
8.2.2 Traditional Diagnostic Technique
8.2.3 Other

8.3 North America Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

8.3.1 Hepatitis C
8.3.2 Hepatitis B
8.3.3 Tuberculosis (TB)
8.3.4 Acquired Immunodeficiency Syndrome (AIDS)
8.3.5 Human Papillomavirus (HPV)
8.3.6 Methicillin-resistant Staphylococcus Aureus (MRSA)

8.4 North America Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America

8.5 North America Infectious Disease Diagnostics Market Attractiveness Analysis

8.5.1 By Type
8.5.2 By Application
8.5.3 By Country

9 Europe Infectious Disease Diagnostics Market Analysis and Forecast

9.1 Key Findings
9.2 Europe Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

9.2.1 Molecular Diagnostic Technique
9.2.2 Traditional Diagnostic Technique
9.2.3 Other

9.3 Europe Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

9.3.1 Hepatitis C
9.3.2 Hepatitis B
9.3.3 Tuberculosis (TB)
9.3.4 Acquired Immunodeficiency Syndrome (AIDS)
9.3.5 Human Papillomavirus (HPV)
9.3.6 Methicillin-resistant Staphylococcus Aureus (MRSA)

9.4 Europe Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe

9.5 Europe Infectious Disease Diagnostics Market Attractiveness Analysis

9.5.1 By Type
9.5.2 By Application
9.5.3 By Country

10 Asia Pacific Infectious Disease Diagnostics Market Analysis and Forecast

10.1 Key Findings
10.2 Asia Pacific Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

10.2.1 Molecular Diagnostic Technique
10.2.2 Traditional Diagnostic Technique
10.2.3 Other

10.3 Asia Pacific Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

10.3.1 Hepatitis C
10.3.2 Hepatitis B
10.3.3 Tuberculosis (TB)
10.3.4 Acquired Immunodeficiency Syndrome (AIDS)
10.3.5 Human Papillomavirus (HPV)
10.3.6 Methicillin-resistant Staphylococcus Aureus (MRSA)

10.4 Asia Pacific Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC

10.5 Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis

10.5.1 By Type
10.5.2 By Application
10.5.3 By Country

11 Latin America Infectious Disease Diagnostics Market Analysis and Forecast

11.1 Key Findings
11.2 Latin America Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

11.2.1 Molecular Diagnostic Technique
11.2.2 Traditional Diagnostic Technique
11.2.3 Other

11.3 Latin America Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

11.3.1 Hepatitis C
11.3.2 Hepatitis B
11.3.3 Tuberculosis (TB)
11.3.4 Acquired Immunodeficiency Syndrome (AIDS)
11.3.5 Human Papillomavirus (HPV)
11.3.6 Methicillin-resistant Staphylococcus Aureus (MRSA)

11.4 Latin America Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

11.4.1 Brazil
11.4.2 Rest of Latin America China

11.5 Latin America Infectious Disease Diagnostics Market Attractiveness Analysis

11.5.1 By Type
11.5.2 By Application
11.5.3 By Country

12 Middle East & Africa (MEA) Infectious Disease Diagnostics Market Analysis and Forecast

12.1 Key Findings
12.2 Middle East & Africa (MEA) Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)

12.2.1 Molecular Diagnostic Technique
12.2.2 Traditional Diagnostic Technique
12.2.3 Other

12.3 Middle East & Africa (MEA) Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

12.3.1 Hepatitis C
12.3.2 Hepatitis B
12.3.3 Tuberculosis (TB)
12.3.4 Acquired Immunodeficiency Syndrome (AIDS)
12.3.5 Human Papillomavirus (HPV)
12.3.6 Methicillin-resistant Staphylococcus Aureus (MRSA)

12.4 Middle East & Africa (MEA) Infectious Disease Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA

12.5 Middle East & Africa (MEA) Infectious Disease Diagnostics Market Attractiveness Analysis

12.5.1 By Type
12.5.2 By Application
12.5.3 By Country

13 Competitive Landscape

13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles

13.3.1 Bio Mérieux SA

13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies

13.3.2 Roche Diagnostics
13.3.3 Abbott Laboratories
13.3.4 Thermo Fischer Scientific
13.3.5 BD
13.3.6 Bio-Rad Laboratories
13.3.7 Abbott
13.3.8 Danaher
13.3.9 Johnson and Johnson
13.3.10 Guangzhou Wondfo Biotech Co.
13.3.11 Ltd.
13.3.12 Getein Biotech
13.3.13 Inc.
13.3.14 Wuhan Easy Diagnosis Biomedicine Co.
13.3.15 Ltd.
13.3.16 BGI Genomics Co.
13.3.17 Ltd.
13.3.18 Maccura Pharmaceuticals & Healthcare Co.
13.3.19 Ltd.
13.3.20 Daan Gene
13.3.21 Beijing Strong Biotechnologies
13.3.22 Inc
13.3.23 Shanghai Kehua Bio-Engineering Co.
13.3.24 Ltd.
13.3.25 Guangdong Hybribio Biotech Co.
13.3.26 Ltd.
13.3.27 Shanghai Runda Medical Technology Co.
13.3.28 Ltd.
13.3.29 Tellgen Corporation

14 Key Takeaways